These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 6324833)

  • 1. Enalapril (MK421) and its lysine analogue (MK521): a comparison of acute and chronic effects on blood pressure, renin-angiotensin system and sodium excretion in normal man.
    Hodsman GP; Zabludowski JR; Zoccali C; Fraser R; Morton JJ; Murray GD; Robertson JI
    Br J Clin Pharmacol; 1984 Mar; 17(3):233-41. PubMed ID: 6324833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacodynamics of converting enzyme inhibition: the cardiovascular, endocrine and autonomic effects of MK421 (enalapril) and MK521.
    Millar JA; Derkx FH; McLean K; Reid JL
    Br J Clin Pharmacol; 1982 Sep; 14(3):347-55. PubMed ID: 6289857
    [No Abstract]   [Full Text] [Related]  

  • 3. Effect of a new angiotensin converting enzyme inhibitor MK 421 and its lysine analogue on the components of the renin system in healthy subjects.
    Brunner DB; Desponds G; Biollaz J; Keller I; Ferber F; Gavras H; Brunner HR; Schelling JL
    Br J Clin Pharmacol; 1981 May; 11(5):461-7. PubMed ID: 6268131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence for a vasodepressor effect of the angiotensin-converting enzyme inhibitor, MK421 (enalapril), independent of blockade of angiotensin II formation.
    Wilkes BM
    J Cardiovasc Pharmacol; 1984; 6(6):1036-42. PubMed ID: 6084759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute effects of MK421, a new angiotensin converting enzyme inhibitor, in man.
    Kasai Y; Abe K; Yasujima M; Tajima J; Seino M; Chiba S; Sato K; Goto T; Omata K; Tanno M
    Tohoku J Exp Med; 1983 Dec; 141(4):417-22. PubMed ID: 6322384
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-sulfhydryl-containing angiotensin-converting enzyme inhibitor (MK421): evidence for role of renin system in normotensive subjects.
    MacGregor GA; Markandu ND; Bayliss J; Roulston JE; Squires M; Morton JJ
    Br Med J (Clin Res Ed); 1981 Aug; 283(6288):401-3. PubMed ID: 6266576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic MK421 fails to modify evolution of hypertension in neonatally coarcted pups.
    Bagby SP; Fuchs EF
    Hypertension; 1989 Feb; 13(2):91-101. PubMed ID: 2536643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of captopril and enalapril on sodium excretion and blood pressure in sodium-deficient dogs.
    McCaa RE; Gillespie JB
    Fed Proc; 1984 Apr; 43(5):1336-41. PubMed ID: 6323226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enalapril (MK421) in the treatment of hypertension with renal artery stenosis.
    Hodsman GP; Brown JJ; Cumming AM; Davies DL; East BW; Lever AF; Morton JJ; Murray GD; Robertson JI
    J Hypertens Suppl; 1983 Oct; 1(1):109-17. PubMed ID: 6100599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of enalapril (MK421), an angiotensin converting enzyme inhibitor, on the conscious pregnant ewe and her foetus.
    Broughton Pipkin F; Wallace CP
    Br J Pharmacol; 1986 Mar; 87(3):533-42. PubMed ID: 3026539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enalapril maleate and a lysine analogue (MK-521) in normal volunteers; relationship between plasma drug levels and the renin angiotensin system.
    Biollaz J; Schelling JL; Jacot Des Combes B; Brunner DB; Desponds G; Brunner HR; Ulm EH; Hichens M; Gomez HJ
    Br J Clin Pharmacol; 1982 Sep; 14(3):363-8. PubMed ID: 6289859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blood pressure response to angiotensin converting enzyme inhibitor in essential hypertension: its relation to the renin status and natriuresis during acute sodium loading.
    Hou CH; Chen YM; Wu KD; Hsieh BS
    J Formos Med Assoc; 1993 Nov; 92(11):942-7. PubMed ID: 7910063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The persistent effect of long-term enalapril on pressure natriuresis in spontaneously hypertensive rats.
    Dukacz SA; Adams MA; Kline RL
    Am J Physiol; 1997 Jul; 273(1 Pt 2):F104-12. PubMed ID: 9249597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Renal adaptation to a restriction of sodium intake in the rat: effects of inhibition of the renin-angiotensin system].
    Jover B; Dupont M; Casellas D; Mimran A
    Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1234-7. PubMed ID: 6098235
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Converting-enzyme inhibitor enalapril (MK421) in treatment of hypertension with renal artery stenosis.
    Hodsman GP; Brown JJ; Davies DL; Fraser R; Lever AF; Morton JJ; Murray GD; Robertson JI
    Br Med J (Clin Res Ed); 1982 Dec; 285(6356):1697-9. PubMed ID: 6293638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of converting enzyme inhibition by enalapril on sodium homeostasis in the rat.
    Jover B; Mimran A
    Br J Clin Pharmacol; 1984; 18 Suppl 2(Suppl 2):209S-214S. PubMed ID: 6099736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous angiotensin II as a determinant of sodium-modulated changes in tissue responsiveness to angiotensin II in normal man.
    Shoback DM; Williams GH; Hollenberg NK; Davies RO; Moore TJ; Dluhy RG
    J Clin Endocrinol Metab; 1983 Oct; 57(4):764-70. PubMed ID: 6309884
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute and chronic effects of the converting enzyme inhibitors enalapril and lisinopril on reflex control of heart rate in normotensive man.
    Ajayi AA; Campbell BC; Howie CA; Reid JL
    J Hypertens; 1985 Feb; 3(1):47-53. PubMed ID: 2987341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of angiotensin I-converting enzyme with S 9490: biochemical effects, interspecies differences, and role of sodium diet in hemodynamic effects.
    Laubie M; Schiavi P; Vincent M; Schmitt H
    J Cardiovasc Pharmacol; 1984; 6(6):1076-82. PubMed ID: 6084763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of sodium intake on physiological responses to angiotensin II in conscious dogs.
    Olsen ME; Meydrech EF
    Scand J Urol Nephrol Suppl; 1984; 79():29-34. PubMed ID: 6089315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.